Forward Therapeutics is a biopharma comapny targeting treatment of chronic inflammatory disorders.
Forward Therapeutics has raised $50.0M in total funding. The most recent round was Series A. The last funding was announced in October 2023.
Forward Therapeutics's investors include RA Capital Management, OrbiMed, Biotechnology Value Fund.
Forward Therapeutics is headquartered in Palm Beach Gardens, United States.
Forward Therapeutics is a biopharma comapny targeting treatment of chronic inflammatory disorders.
Forward Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Forward Therapeutics — Funding & Investors." VCBacked, October 31, 2023, https://www.vcbacked.co/company/forward-therapeutics. Accessed November 13, 2026.
VCBacked. (2023). Forward Therapeutics — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/forward-therapeutics
{{cite web |title=Forward Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/forward-therapeutics |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Forward Therapeutics? Request a listing update